India’s human-brain research programme is expanding with a new effort to create detailed three-dimensional maps of more than 100 human brains, allowing scientists to examine the organ’s structure at cellular resolution across different stages of life.
The mission is being undertaken by the Sudha Gopalakrishnan Brain Centre (SGBC) at the Indian Institute of Technology Madras in Chennai. On October 11, 2026, Prime Minister Narendra Modi dedicated the centre to the nation and released C-STROKE, a specialised atlas documenting microscopic changes in a human brain affected by ischaemic stroke.
Editorial Insight
Key Highlights
Important points readers should notice.
Issue/Event: IIT Madras launched a mission to create three-dimensional, cellular-resolution maps of more than 100 human brains and released the C-STROKE atlas of ischaemic stroke tissue.
Location: Sudha Gopalakrishnan Brain Centre, Indian Institute of Technology Madras, Chennai, Tamil Nadu.
Authority/Organisation: IIT Madras, Sudha Gopalakrishnan Brain Centre and the Prime Minister’s Office.
Action Taken: Prime Minister Narendra Modi dedicated the centre to the nation on October 11, 2026, and released C-STROKE, which contains more than 1,000 annotated microscopic sections from a stroke-affected brain.
Impact: The research resource may help scientists study the cellular changes associated with stroke and compare microscopic tissue features with clinical MRI findings. It is not yet a proven diagnostic or treatment tool.
The initiative aims to build a large collection of digital whole-brain maps spanning the human lifespan, from the foetal stage to old age, including brains affected by neurological diseases. By combining high-resolution imaging, tissue analysis and computational reconstruction, researchers seek to understand how brain structures and cells vary across development and disease.
The C-STROKE atlas is a specific component of this wider research effort. It contains more than 1,000 annotated microscopic sections from a stroke-affected human brain. The resource links magnetic resonance imaging (MRI) scans obtained before death with high-resolution microscopic examination of the brain tissue, creating a way to investigate how patterns visible in clinical scans relate to cellular-level changes.
The research could help scientists investigate the biological processes involved in stroke damage and identify questions for future studies. It does not, however, establish that a new treatment has been developed or that the atlas can currently predict recovery or determine the best treatment for an individual patient.
Editorial Analysis
Why This Matters
Brain atlases provide researchers with a shared reference for examining anatomy and comparing data across specimens. By connecting MRI scans with microscopic tissue analysis, C-STROKE offers a way to investigate how visible patterns in clinical imaging relate to cellular-level changes in stroke-affected tissue. The broader mission could strengthen neuroscience research in India by expanding the availability of detailed three-dimensional brain maps across different ages and neurological conditions. The clinical value will depend on what subsequent research establishes. More detailed anatomical information can support scientific discovery, but potential therapies and diagnostic applications must be tested and validated before they can be recommended for patients.
What is the Sudha Gopalakrishnan Brain Centre?
The Sudha Gopalakrishnan Brain Centre is a research centre at IIT Madras focused on high-resolution imaging and digital mapping of the human brain.
The centre was established in 2022 with philanthropic support from Sudha and Kris Gopalakrishnan. Its work brings together neuroscience, engineering, advanced imaging and computing to create detailed digital representations of brain anatomy.
Traditional brain imaging provides information at different scales. Clinical MRI scans can show large-scale structures and abnormalities, while microscopic examination of tissue can reveal details about individual cells and the organisation of brain tissue. Researchers can use digital reconstruction to connect these levels of observation.
The centre’s broader mission is to map more than 100 human brains into three-dimensional atlases at cellular resolution. The planned collection is intended to represent different ages and conditions, helping researchers compare the organisation of healthy and diseased brain tissue.
Such a resource can be valuable because the human brain is highly complex. Its functions depend on specialised cell types, networks of connections and the organisation of tissue across multiple anatomical levels. A digital atlas can help researchers locate structures, compare specimens and share a common reference for studying the brain.
The October 11 dedication marked a public milestone for the centre and its research programme. It should not be interpreted as the date on which the centre first came into existence, since the institution and its research activities predate the event.
What is C-STROKE?
C-STROKE is a specialised atlas of human ischaemic stroke tissue developed at the Sudha Gopalakrishnan Brain Centre.
An atlas in neuroscience is a structured reference that helps researchers identify and examine anatomical features. A digital brain atlas can contain images of brain sections, labelled structures and information that allows users to navigate between different levels of detail.
C-STROKE focuses on a brain affected by ischaemic stroke. The atlas contains more than 1,000 annotated microscopic sections, with information about cellular features associated with neuronal health, inflammation, disruption of the blood-brain barrier, reduced oxygen availability and injury to nerve fibres.
One of its important features is the connection between MRI scans taken while the individual was alive and microscopic examination of the brain tissue after death. Clinical MRI can reveal areas of concern at a millimetre-scale level, while histology—the microscopic study of tissue—can show more detailed structural and cellular changes.
By aligning these types of information, researchers can investigate how visible imaging patterns relate to the underlying biology of damaged tissue.
IIT Madras describes C-STROKE as the world’s first human ischaemic stroke atlas of its kind. That claim refers to the specific resource developed by the centre; it should not be interpreted as meaning that all stroke imaging or brain-atlas research began with this project.
Why mapping stroke-affected brain tissue matters
An ischaemic stroke occurs when blood flow to part of the brain is blocked, often by a clot. Without an adequate blood supply, brain tissue receives less oxygen and nutrients, potentially causing injury or cell death.
The effects vary according to the location and extent of the affected area, how quickly blood flow is restored and other clinical factors. A stroke can affect movement, speech, vision, memory or other functions, depending on the parts of the brain involved.
Doctors already use clinical examination and imaging to diagnose stroke and guide urgent treatment. However, the biological changes occurring inside damaged tissue are complex, and researchers continue to investigate how those changes relate to imaging findings, disease progression and recovery.
A detailed atlas can help scientists examine these processes at a microscopic level. It provides a structured reference for comparing areas of tissue and identifying cellular features associated with injury.
For example, researchers can investigate how neuronal damage, inflammation and changes to the blood-brain barrier are distributed within stroke-affected tissue. They can then study whether particular microscopic patterns correspond to features observed in MRI scans.
This work may help generate hypotheses about why some areas of tissue are more severely affected than others, how different injury mechanisms interact and which biological pathways deserve further investigation.
The atlas is therefore valuable as a research platform. Its contribution is to make detailed anatomical and cellular information easier to examine and compare—not to replace emergency stroke assessment, established imaging procedures or clinical decisions.
How a 3D brain atlas is created
Producing a three-dimensional digital atlas involves multiple stages of imaging, tissue processing, annotation and computational reconstruction.
First, researchers obtain brain specimens and document relevant information about the tissue, subject to the applicable ethical and research requirements. For post-mortem brain studies, the team can prepare serial tissue sections for microscopic examination.
The sections are digitally imaged at high resolution. Researchers then identify and annotate relevant structures or cellular features so that the images can be interpreted and compared.
Computational tools help align the sections and reconstruct them into a three-dimensional representation. This allows researchers to move between individual microscopic sections and a broader view of the brain’s anatomy.
For C-STROKE, the additional challenge is to connect the microscopic information with clinical MRI obtained before death. The resulting resource links observations made at different scales, helping researchers investigate the tissue changes associated with imaging patterns.
The centre has used advanced computing infrastructure, including the PARAM Shakti supercomputer supported by the Ministry of Electronics and Information Technology, for its brain-mapping work.
The quality and usefulness of an atlas depend on factors such as tissue preservation, image quality, the accuracy of annotations and how well the different imaging datasets are aligned. These are important considerations when researchers use the resource to draw conclusions about brain structure and disease.
What could researchers learn from the atlas?
The immediate scientific value of C-STROKE is that it creates a detailed reference for studying the cellular features of stroke-affected tissue.
Researchers may use the atlas to investigate how neuronal health, neuroinflammation, blood-brain barrier disruption, hypoxia and axonal injury are distributed in the examined specimen. The data may also help scientists explore the relationship between clinical imaging and microscopic changes.
Over time, resources of this kind could contribute to research into cerebrovascular disease, including the development of more precise research questions about injury mechanisms and potential therapeutic targets.
The wider mission to map more than 100 brains could add further opportunities for comparison. If the collection includes a sufficiently broad range of ages and neurological conditions, researchers may be able to examine differences across development, ageing and disease.
However, an atlas built from a particular specimen does not automatically represent every person who experiences a stroke. Brain structure and injury can vary substantially, and a larger collection will be needed to understand the range of patterns found across individuals.
The next stage of scientific work will involve using the data to test hypotheses, compare specimens and validate observations in independent research. Potential clinical applications would require additional evidence and appropriate evaluation.
What C-STROKE cannot promise yet
C-STROKE should not be described as a new cure for stroke, a method of reversing brain damage or a tool that can independently select treatment for a patient.
It is a research atlas based on detailed examination of stroke-affected brain tissue. It helps scientists investigate the relationship between imaging and microscopic anatomy, but the public release of an atlas is not the same as clinical validation of a diagnostic or therapeutic technology.
The atlas also does not, by itself, establish how accurately a particular imaging feature predicts an individual patient’s recovery. Such questions require studies involving appropriate patient groups, validated methods and clinical outcomes.
Similarly, identifying a possible therapeutic target is an early step in research. A target must be investigated experimentally and clinically before researchers can determine whether it can safely and effectively be used to prevent or treat disease.
For people experiencing stroke symptoms, the practical advice remains unchanged: seek emergency medical care immediately. A research atlas is not a substitute for urgent assessment, brain imaging or treatment delivered by qualified clinicians.
India’s wider brain-mapping research effort
The new mission builds on earlier work at the Sudha Gopalakrishnan Brain Centre.
In 2024, the centre released Dharani, a three-dimensional atlas of the human foetal brain comprising digital images of 5,132 brain sections. In June 2026, it released ANCHOR, an atlas focused on the neurochemical characterisation and three-dimensional reconstruction of the human brainstem.
These projects demonstrate the range of anatomical scales that brain atlases can address. The foetal-brain atlas focuses on early development, while ANCHOR maps structures in the brainstem, a region involved in essential functions such as breathing, heart rate and consciousness.
C-STROKE adds a disease-focused resource centred on the microscopic features of ischaemic stroke. Together, these projects provide examples of how digital mapping can be used to study different regions, developmental stages and neurological conditions.
The broader mission aims to expand this work into a collection of more than 100 whole-human-brain maps. According to reporting on the launch, the effort brings together more than 200 researchers, engineers and technicians, along with medical institutions and international collaborators.
The long-term scientific value will depend on the quality, accessibility and responsible use of the data, as well as the research findings produced by teams that use the maps.
